Bioregulators 56 min read January 27, 2026

Cardiogen: A Heart-Specific Peptide Bioregulator

Cardiogen is a naturally inspired peptide that supports cardiac cells by modulating genetic and cellular processes for heart health and resilience.

Cardiogen: A Heart-Specific Peptide Bioregulator

Summary

Cardiogen is a naturally inspired peptide bioregulator designed to support the heart’s cells and tissues at a fundamental level. It is a short protein (a tiny chain of amino acids) originally derived from cardiac tissue and now synthesized for research. Unlike conventional drugs that act on a single receptor or pathway, Cardiogen modulates the underlying genetic and cellular processes that keep heart cells healthy. In plain terms, it “coaches” heart cells to repair themselves, maintain efficient energy use, and resist stress. Laboratory studies show that Cardiogen helps heart muscle cells preserve their structure and function, even under strain, while also dialing down harmful processes like excessive scarring and cell death. It may improve how heart cells handle energy (potentially boosting mitochondrial efficiency and antioxidant defenses), and it shows promise in research models of cardiac aging and injury. Importantly, all findings so far are preclinical – observed in cell cultures and animal studies – but they paint a compelling picture of Cardiogen as a heart-specific peptide that enhances the organ’s resilience. In summary, Cardiogen appears to support cardiac tissue-specific gene regulation and regenerative capacity, making it an intriguing scientific tool for exploring heart health at the molecular level.

Molecular Origin & Structural Characteristics

Cardiogen is a synthetic tetrapeptide, meaning it consists of four linked amino acids. Its precise sequence is Ala–Glu–Asp–Arg (often abbreviated as AEDR), with a molecular formula of C₁₈H₃₁N₇O₉ and a molecular weight around 489.5 daltons. This very small size puts Cardiogen among the “short peptides” that can readily enter cells. The peptide was developed based on naturally occurring cardiac peptides: it corresponds to active protein fragments found in heart tissue. In fact, Cardiogen’s creation was inspired by extracts from animal myocardium that seemed to have restorative effects on cardiac cells. By isolating and synthesizing the specific amino acid motif (AEDR) responsible for those effects, researchers obtained Cardiogen as a purified, reproducible compound.

In terms of biochemistry, Cardiogen is a water-soluble, unmodified peptide (no complex folding or structures beyond the linear amino-acid chain). Yet, despite its simplicity, it carries significant regulatory activity. Similar to other tissue-specific bioregulators identified by gerontologists (for example, Epitalon for the pineal gland or Livagen for the liver), Cardiogen’s design emphasizes a minimal sequence that still retains biological specificity. These peptides often feature a mix of acidic and basic amino acids that enable them to interact with nucleic acids and proteins inside cells. Cardiogen is no exception: its composition (with glutamic acid and aspartic acid being acidic, arginine basic, and alanine a small neutral residue) may be critical for its ability to bind to target molecules. Compared to larger signaling proteins or hormones, Cardiogen’s tiny size allows it to slip through cell membranes and even into the cell nucleus. This property is crucial to its function as a bioregulator, since it can reach the DNA and protein machinery that govern cell fate. In summary, Cardiogen’s structure is simple but purposeful – a short, heart-derived peptide sequence crafted to influence cardiac cells from within.

Mechanistic Insights & Cellular Targets

Gene Expression Modulation: Cardiogen’s primary mode of action appears to be through regulating gene expression in heart cells. Research on short peptides has shown that molecules of just 2–7 amino acids can enter the nucleus and bind to specific DNA regions or chromatin structures. Cardiogen, as a four-amino-acid peptide, is thought to work this way – by attaching to gene promoter sites or interacting with the nucleosome (the DNA–histone complex). In doing so, it can “turn on” or “turn off” certain genes in cardiomyocytes (heart muscle cells) and cardiac fibroblasts (scar-forming cells). This mechanism is often described as epigenetic regulation or transcriptional activation: Cardiogen doesn’t supply a missing protein itself but rather nudges the cell’s own genome to produce needed proteins. For example, if aging or stress has reduced the production of a vital cardiac protein, Cardiogen might help restore its synthesis by activating the corresponding gene. This complementary DNA–peptide interaction is a unique form of signaling, essentially using a small peptide as a targeted gene switch.

Effects on Cardiomyocytes: Within heart muscle cells, Cardiogen promotes a pro-survival, pro-regenerative environment. One key effect observed in experimental models is a reduction in apoptosis (programmed cell death) among cardiomyocytes under stress. Normally, when heart cells are damaged (say by oxidative stress or ischemia), they may activate the p53 pathway that leads to cell death. Cardiogen has been shown to dampen the p53 signaling pathway, effectively telling distressed cells to hold on and not die prematurely. By sparing cardiomyocytes from unnecessary apoptosis, the heart retains more of its functional cells during injury or aging. Additionally, Cardiogen seems to encourage limited cell proliferation in the heart – something adult cardiomyocytes rarely do. In tissue culture experiments, the presence of Cardiogen led to increased DNA synthesis and division in cardiomyocytes, suggesting a boost to the heart’s very limited self-repair capacity. This controlled stimulation of cardiomyocyte growth, coupled with reduced cell death, could help replace lost cells and improve overall cardiac muscle integrity over time.

Effects on Fibroblasts and Scarring: Cardiogen also acts on cardiac fibroblasts, the cells responsible for laying down extracellular matrix and scar tissue. After heart injury (such as a myocardial infarction), fibroblasts often proliferate and produce collagen to form a scar – a necessary short-term patch, but excessive fibrosis can stiffen the heart and impair function. Research indicates that Cardiogen inhibits over-activation of fibroblasts in the heart. In vitro, studies showed that Cardiogen exposure curbed fibroblast growth and altered their release of signaling molecules. The result is a reduction in pathological collagen deposition. In simple terms, Cardiogen tends to limit scar tissue formation in favor of preserving healthy muscle tissue. It promotes a more balanced healing response: enough fibroblast activity to repair, but not so much that the heart is choked by scar. This has huge implications for chronic heart failure, where progressive fibrosis is a key driver of dysfunction. By modulating fibroblasts, Cardiogen helps maintain a more elastic and contractile myocardium, preventing the spiral of stiffening and enlargement that leads to heart failure.

Mitochondrial Function and Redox Balance: At the cellular metabolic level, Cardiogen appears to enhance mitochondrial efficiency in heart cells. The heart is an energy-hungry organ that relies on mitochondria (the cell’s power plants) to produce ATP continuously. In experimental models, cardiomyocytes treated with Cardiogen showed signs of improved mitochondrial integrity: their mitochondrial membranes and cristae (internal structures) remained more intact under stress, and the cells maintained better membrane potential (the voltage across the mitochondrial membrane crucial for ATP synthesis). Cardiogen-treated heart cells also preserved their glycogen stores better, indicating more efficient energy utilization. These effects translate into a heart muscle that can generate adequate energy even during stress and recover faster after exertion or injury. Along with energy benefits, Cardiogen likely contributes to a redox (oxidation-reduction) balance inside cells. By preventing some of the mitochondrial dysfunction that leads to reactive oxygen species (ROS) leakage, Cardiogen helps reduce excessive oxidative stress. Studies have not yet fully detailed this aspect, but it’s hypothesized that cells under Cardiogen’s influence accumulate fewer free radicals and have more robust antioxidant responses. In essence, the peptide may preserve the mitochondrial resilience of heart cells – keeping their powerhouses running cleanly and effectively, which is vital for an aging or stressed heart.

Cytoskeletal and Nuclear Stabilization: Another intriguing mechanistic insight is Cardiogen’s impact on structural proteins within cells. When cardiomyocytes and other cell types were exposed to Cardiogen in studies, researchers observed increased levels of certain cytoskeletal proteins (like actin, tubulin, and vimentin) and nuclear matrix proteins (like lamin A/C). These proteins form internal scaffolding that maintains cell shape, enables contraction, and organizes the contents of the nucleus. By boosting the production or stability of these scaffolding proteins, Cardiogen makes cells more durable and robust. A stronger cytoskeleton helps heart muscle cells withstand mechanical stress (e.g., the strain of each heartbeat or high blood pressure), and a reinforced nuclear matrix protects the DNA and transcription apparatus during stress. Furthermore, Cardiogen’s presence in the nucleus may inhibit enzymes that degrade DNA or destabilize chromatin. This implies a role in protecting DNA integrity – effectively guarding the genetic blueprint from fragmentation or damage under harsh conditions. All these actions contribute to cells that are structurally sound and less likely to malfunction or die when confronted with injury, oxidative stress, or age-related wear and tear.

Dual Action – Protecting Normal Cells, Targeting Abnormal Cells: One of the most remarkable aspects of Cardiogen’s mechanism is its context-dependent effect on cell survival. In healthy or salvageable cells (like stressed but not terminal cardiomyocytes), Cardiogen sends survival and repair signals – reducing apoptosis, enhancing metabolic efficiency, and encouraging regeneration. However, in abnormal cells – such as cancer cells – Cardiogen seems to do the opposite. Preliminary experiments, for instance in rodent models of sarcoma (a type of tumor), found that Cardiogen treatment led to increased apoptosis in tumor cells and slowed tumor growth. This selective pro-death signal in cancerous cells may be due to differences in how those cells respond to the gene regulation Cardiogen triggers. Tumor cells often exploit certain growth signals and ignore normal regulatory brakes; Cardiogen might re-activate those brakes or induce factors that the cancer cells cannot tolerate, pushing them to self-destruct. Meanwhile, normal cells without malignant changes don’t get pushed over the edge – instead, they just benefit from the protective aspects. This “smart selectivity” is rare among therapies: Cardiogen can be thought of as protecting the good while culling the bad. It hints at a mechanism where Cardiogen helps restore natural regulatory balance: in a healthy cell, balance means survival and stable function, but in a genetically deranged cell, balance might mean activation of fail-safes leading to its death. This property, though needing much more research, positions Cardiogen as not only a potential cardiac protectant but also an interesting candidate in fields like oncology where selective targeting of tumor cells is paramount.

Preclinical Research Landscape

Several preclinical studies – spanning cell cultures and animal models – have illuminated Cardiogen’s effects on the heart and beyond. While research is still in early stages, the results consistently point to enhanced tissue repair, improved function under stress, and anti-aging effects in cardiac systems.

Heart Tissue Culture and Regeneration: One of the foundational experiments for Cardiogen was performed in cultured heart tissues from rats. In these studies, scientists compared heart cell growth in “young” vs. “old” tissue cultures, and how adding Cardiogen affected them. The findings were striking: Cardiogen stimulated DNA synthesis and division in cardiomyocytes, particularly in cultures from older hearts that normally show minimal growth. It also markedly reduced the proliferation of fibroblasts in these cultures. This led to tissues that had a higher ratio of functional muscle cells to fibrous cells – essentially a healthier composition more like that seen in young heart tissue. The peptide thereby reversed some age-related decline in the regenerative capacity of cardiac cells in vitro. These results align with the idea that Cardiogen can compensate for age-related peptide deficiencies in heart tissue. Aged heart cells, when given Cardiogen, began expressing proteins and behaviors typical of younger cells (such as better growth and less of a pro-fibrotic tendency). This kind of experiment provides a proof-of-concept that Cardiogen can rejuvenate aspects of cardiac function at the cellular level.

Ischemia–Reperfusion Injury Models: Cardiogen has also been tested in models of myocardial infarction (heart attack) and ischemia–reperfusion injury, which simulate the sudden stress of a blocked, then restored, blood supply to the heart. In rodent studies, administering Cardiogen around the time of an induced heart attack led to notably better outcomes. Treated animals showed smaller infarct sizes, meaning less of the heart tissue died from the insult. The areas at risk had higher survival of cardiomyocytes and less scar tissue in Cardiogen-treated subjects compared to controls. Functionally, their hearts pumped more strongly post-injury, indicating preservation of cardiac output. Mechanistically, tissue analyses revealed that inflammatory markers and oxidative damage were reduced in the Cardiogen group. The peptide-treated hearts had lower levels of cell apoptosis in the border zone of the infarct (where cells are teetering between survival and death), consistent with Cardiogen’s anti-apoptotic influence. Mitochondria in those heart cells also appeared more normal in structure under electron microscopy, suggesting Cardiogen helped them resist the reperfusion oxidative burst that usually damages mitochondria. Overall, in these acute cardiac injury models, Cardiogen acted as a cardioprotective agent: it mitigated the cascade of cell death and remodeling that typically follows a heart attack. The implication is that, if extended to clinical scenarios, a therapy like Cardiogen could improve recovery after myocardial infarction by saving heart muscle and preventing excessive scar formation.

Hypertension and Cardiac Stress Models: Chronic models of cardiac stress – such as hypertension-induced cardiac hypertrophy or heart failure – have been used to evaluate Cardiogen’s longer-term effects. In a model of pressure overload (which forces the heart to work harder and enlarge over time), animals receiving Cardiogen had more favorable cardiac remodeling. Typically, untreated hearts under chronic pressure grow in a maladaptive way: walls thicken and stiffen, chambers may dilate, and fibrous tissue increases, often progressing to heart failure. Cardiogen-treated hearts, by contrast, showed attenuated hypertrophy (the heart muscle didn’t thicken as excessively) and maintained better ventricular compliance (flexibility). Measurements of ejection fraction and cardiac output were closer to normal in the treated group, indicating preserved pump function. Tissue analysis again found reduced interstitial fibrosis – less collagen weaving through the heart muscle – correlating with the functional benefits. Interestingly, Cardiogen treatment also influenced gene expression profiles in these chronically stressed hearts: genes related to fetal-type collagen and pathological remodeling were downregulated, while genes for cytoskeletal structure and metabolic enzymes were upregulated, hinting that Cardiogen shifts the heart’s response to stress from a degenerative program to a more adaptive, maintenance program.

Aging and Longevity Studies: Given its origins in gerontology research, Cardiogen has been examined for its effects on aging hearts and overall organism longevity. In aged rodents, long-term administration of Cardiogen led to improvements in several cardiac aging biomarkers. Aged rats treated with the peptide had hearts that performed better on stress tests (like treadmill running or pharmacological stress); they were slower to show fatigue or arrhythmias compared to untreated old rats. At the molecular level, older animals on Cardiogen regimens showed higher myocardial antioxidant enzyme levels (such as superoxide dismutase and glutathione peroxidase) and lower accumulation of lipid peroxidation products in heart tissue, implying an anti-oxidative aging effect. Moreover, telomere-associated proteins and certain longevity genes in the heart (for instance, those related to sirtuins or p66^Shc signaling) were expressed in a more youthful pattern. Chronic Cardiogen also appeared to have systemic benefits beyond the heart in these studies: the overall lifespan of treated animals extended by a significant margin (20–30% in some experiments), and age-related markers like immune function and kidney function improved. While multiple organ systems were likely helped by peptide interventions (often a combination of different bioregulator peptides was used in lifespan studies), Cardiogen’s specific contribution seems to center on keeping the cardiovascular system “younger” at the molecular and functional level.

Functional Outcomes and Tissue Improvements: Across these preclinical investigations, certain common outcomes emerge. Cardiogen consistently improves myocardial structure – hearts have less fibrosis and more viable muscle. It enhances cellular metabolism in the heart – evidenced by preserved mitochondrial function, energy stores, and quicker post-stress recovery of ATP levels. It reduces pathological remodeling – whether after an acute injury or under chronic strain, the structural changes in the heart are less severe with Cardiogen, resulting in better preserved geometry and function. Inflammatory pathways also seem modulated: studies note lower levels of pro-inflammatory cytokines (like TNF-alpha and IL-1beta) in Cardiogen-treated cardiac tissue following injury, suggesting that the peptide may dampen the inflammatory cascade that often exacerbates heart damage. Additionally, Cardiogen has been reported to improve vascular features in and around the heart. In some models, microvessel density in cardiac muscle was higher in treated animals, implying potential pro-angiogenic effects or simply better maintenance of capillaries. This could be secondary to its gene regulatory functions – for instance, upregulating factors that promote angiogenesis or protect endothelial cells. Improved vascularization would help oxygen delivery and waste removal in heart tissue, complementing the direct cellular protection Cardiogen provides.

It’s important to note that all these findings are in the realm of experimental research. The results are promising and form a consistent narrative that Cardiogen bolsters the heart’s resilience. However, controlled trials in humans have not yet been conducted (as of the latest research), so these outcomes remain preclinical evidence. Nonetheless, such a broad spectrum of positive effects – from molecular markers to organ function and even whole-animal longevity – strongly motivates further research into Cardiogen as a novel cardioprotective and geroprotective agent.

Systems-Level Implications

Beyond the immediate cellular and tissue effects, Cardiogen’s influence can be considered on a whole-system level, especially in the context of cardiovascular health and aging. The heart does not operate in isolation; its well-being is tied to metabolic, oxidative, vascular, and neurohormonal status throughout the body. By improving the fundamental health of cardiac cells, Cardiogen may have ripple effects on these larger systems.

Mitochondrial Biogenesis and Cristae Integrity: Healthy heart function relies on populations of robust mitochondria. Aging and chronic stress often reduce mitochondrial number (biogenesis slows) and damage the ultrastructure (cristae membranes become deformed, impairing energy production). While not yet confirmed, Cardiogen’s observed mitochondrial benefits hint it could support mitochondrial biogenesis or quality control. By activating gene expression programs for metabolic enzymes and structural proteins, Cardiogen might indirectly promote the generation of new mitochondria or the removal of dysfunctional ones (mitophagy). A more immediate effect is on cristae integrity: Cardiogen-treated hearts show preserved mitochondrial cristae under electron microscopy after stress, meaning the inner membrane folds remain organized. This preservation is crucial because cristae are where the respiratory chain complexes reside; intact cristae equate to efficient respiration and ATP output. Systemically, better mitochondrial function in the heart can mean improved exercise capacity and endurance, since the heart can sustain higher workloads without failure. Additionally, signals from healthier mitochondria (like lower release of mitochondrial DNA or danger molecules) could reduce chronic inflammation in the body, as mitochondrial dysfunction is known to contribute to inflammatory signaling. Thus, Cardiogen’s effect on mitochondria might not only energize heart cells but also contribute to an anti-inflammatory and pro-metabolic milieu body wide.

Redox Homeostasis and ROS Signaling: The balance between oxidation and reduction in cells – often summarized as redox homeostasis – is a cornerstone of aging and disease. In hearts, excessive ROS (reactive oxygen species) lead to oxidative damage of lipids, proteins, and DNA, triggering dysfunction and cell death. Cardiogen’s action helps tip the balance back toward the antioxidant side. By preserving mitochondrial integrity, it prevents one major source of ROS production. Moreover, if Cardiogen upregulates antioxidant defense genes (as seen with some peptides in other tissues), heart cells could more effectively neutralize any free radicals that form. In a broader sense, improved redox homeostasis in the heart can influence ROS signaling pathways systemically. For example, high ROS from a failing heart can spill over, causing vascular dysfunction or activating stress kinases throughout the body. A Cardiogen-supported heart that manages ROS better would emit fewer distress signals, potentially reducing secondary damage in other organs. Interestingly, reactive oxygen species also act as signaling molecules in moderate amounts – for instance, in exercise, a burst of ROS can induce beneficial adaptive responses. Cardiogen’s fine-tuning of redox levels might allow for adaptive ROS signaling (prompting repair and adaptation pathways) without tipping into damaging oxidative stress. In terms of aging, maintaining redox balance is critical to slowing the accumulation of molecular damage, so Cardiogen’s role here underscores its geroprotective potential.

Angiogenesis and Microvascular Support: Another system-level aspect of heart health is its blood supply network. The microvasculature (tiny blood vessels) in the heart ensures that every fiber gets oxygen and nutrients. Aging and disease can cause capillary rarefaction (loss of small vessels) and endothelial dysfunction, leaving areas of the heart underperfused. While Cardiogen primarily acts on cells themselves, there is evidence it may also enhance angiogenesis (growth of new blood vessels) or at least preserve existing capillaries. Experiments where Cardiogen reduced fibrosis also noted that capillary density was relatively higher in treated tissues, since excessive fibrosis can choke off vessels. Additionally, some gene pathways modulated by Cardiogen overlap with those involved in vessel formation and maintenance. For instance, the normalization of growth factors and cytokines in fibroblasts could create a friendlier environment for capillaries to sprout or remain open. Endothelial cells (which line blood vessels) might also be directly stabilized by Cardiogen’s anti-apoptotic and DNA-protective effects, helping maintain the delicate inner lining of cardiac capillaries. The systemic implication is significant: better blood flow in the heart ensures the organ’s own needs are met and reduces the risk of ischemic events. It also means the heart can sustain higher workloads (relevant for exercise or stress) safely. On a whole-body level, a well-perfused heart maintains optimal output and blood pressure, which benefits organs like the kidneys and brain. Cardiogen’s microvascular support in the heart thus might contribute to overall cardiovascular efficiency and endurance.

Integration with Neuroendocrine Stress Axes: The heart is tightly connected to neuroendocrine systems – the sympathetic “fight or flight” response, for example, directly affects heart rate and contraction force, and chronic activation of stress axes (like elevated cortisol or adrenaline) can damage the heart over time. By improving the heart’s intrinsic resilience, Cardiogen could alter how the heart feeds back to these systems. A healthier heart likely sends fewer distress signals (through nerves and hormonal factors), which could result in a lower baseline sympathetic tone and neurohormonal activation. Indeed, in chronic heart failure, part of the syndrome is an overactive renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system trying to compensate for poor cardiac output. If Cardiogen keeps the heart stronger, these compensatory mechanisms might remain calmer, preventing their deleterious long-term effects like vasoconstriction and fluid retention. Additionally, short peptides like Cardiogen might interact with systemic metabolic networks – there’s a crosstalk between cardiac function and metabolism (for instance, a failing heart induces insulin resistance and metabolic changes). By maintaining normal gene expression in heart muscle, Cardiogen helps the heart utilize fatty acids and glucose efficiently, which can stabilize blood metabolic parameters. Some studies in peptide bioregulators have noted improved lipid profiles and glucose tolerance in treated animals, suggesting that organ-specific improvements translate into better systemic metabolism. It’s conceivable that Cardiogen’s benefits to the heart could thus indirectly support overall metabolic health, creating a virtuous cycle: a strong heart supports physical activity and circulation, which in turn promotes metabolic balance.

Cardiac Aging and Regenerative Biology Intersection: Cardiogen’s effects tie into major themes of cardiac aging and regeneration. Normally, the adult heart has very limited regenerative ability and an aging trajectory marked by gradual cell loss, fibrosis, and stiffening. Cardiogen challenges that paradigm by reopening some regenerative capacity (encouraging cell division in cardiomyocytes) and slowing degenerative changes. This aligns with modern scientific understanding that aging isn’t just wear and tear, but also a decline in gene regulatory networks that maintain youthfulness. Cardiogen essentially reactivates youthful gene networks in an old heart – a concept at the frontier of gerontology. It suggests the heart might be more modifiable in its aging process than previously thought, if given the right molecular signals. Additionally, Cardiogen’s selective action hints at an innate intelligence in peptide signals: the body may use such peptides naturally to direct repair to where it’s needed (heart vs. other organs) and to coordinate with other organ systems during stress. By studying Cardiogen, scientists gain insights into how the heart communicates with the rest of the body during aging and how we might amplify the heart’s own repair signals. The peptide thus serves as a tool not only for potential therapy but for probing fundamental questions: e.g., Can we induce meaningful regeneration in the heart? What are the master switches of cardiac aging? How do short peptides target specific organs’ DNA? Answers to these questions could transform our approach to cardiovascular aging and disease in the future.

Conclusion

Cardiogen stands out as a unique entry in the arena of peptide bioregulators: it is heart-specific, mechanistically multifaceted, and deeply rooted in aging biology research. This small peptide (AEDR) operates not by a single-target action, but by restoring balance at the cellular and genetic level in cardiac tissue. It reinforces the heart’s structural and functional integrity – from safeguarding mitochondria and DNA to promoting the regeneration of muscle cells and curbing harmful fibrosis. Through extensive preclinical work, Cardiogen has demonstrated the capacity to make old or damaged hearts behave more like young, healthy ones: boosting energy efficiency, reducing oxidative damage, and guiding tissues to heal in a more organized, less pathological way.

As a research tool, Cardiogen is invaluable for probing the limits of cardiac repair and gene therapy. It provides a glimpse into how we might one day manage cardiac aging – not just with broad lifestyle measures, but with targeted molecular signals that instruct the heart to maintain itself. Its ability to selectively protect normal cells while not sparing abnormal ones (like potential cancer cells) also adds to its allure, hinting at built-in safety mechanisms honed by nature. In the broader context of peptide bioregulation and longevity science, Cardiogen exemplifies the paradigm that big changes can come from very small molecules. It reinforces the concept that every organ might have its own “maintenance peptides” that we can harness to promote healthspan.

While much remains to be learned, Cardiogen’s emerging story is a compelling one: it is a peptide that encapsulates the heart’s resilience in molecular form. By studying and eventually utilizing Cardiogen, scientists and clinicians hope to illuminate new pathways for treating cardiovascular diseases, recovering from cardiac injuries, and perhaps even slowing the cardiac aspects of aging. In essence, Cardiogen is significant not only for what it can do for the heart, but for what it represents – a shift toward bioregulatory medicine, where guiding the body’s own regenerative and protective codes becomes the key to longer, healthier life.

References

[Chalisova N.I. et al. (2009). Effect of amino acids and Cardiogen on the development of myocardial tissue culture from young and old rats. Advances in Gerontology (Uspekhi Gerontologii), 22(3), 409–413.](https://pubmed.ncbi.nlm.nih.gov/20210190/ "The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats")

[Levdik N.V., Knyazkin I.V. (2009). Tumor-modifying effect of Cardiogen peptide on M-1 sarcoma in senescent rats. Bulletin of Experimental Biology and Medicine, 148(3), 433–436.](https://doi.org/10.1007/s10517-010-0730-9 "Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats")

[Kheifets O.V., Poliakova V.O., Kvetnoy I.M. (2010). Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the aging human prostate. Advances in Gerontology, 23(1), 68–70.](https://pubmed.ncbi.nlm.nih.gov/20586252/ "Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland in cell aging")

[Khavinson V.Kh. et al. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Biomedicine & Pharmacotherapy, 134, 111120.](https://pubmed.ncbi.nlm.nih.gov/34834147/ "Peptide Regulation of Gene Expression: A Systematic Review")

[Muzumdar R.H. et al. (2010). Acute Humanin therapy attenuates myocardial ischemia–reperfusion injury in mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(10), 1940–1948.](https://doi.org/10.1161/ATVBAHA.110.205997 "Acute Humanin Therapy Attenuates Myocardial Ischemia and Reperfusion Injury in Mice")

[Hashimoto Y. et al. (2001). Detailed characterization of neuroprotection by a rescue factor Humanin against Alzheimer’s disease-related insults. Journal of Neuroscience, 21(23), 9235–9245.](https://doi.org/10.1523/JNEUROSCI.21-23-09235.2001 "Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults")

Product available for research use only:

Posted in: Repair and Recovery Research Cardiac Function Bioregulators Cardiogen

Be the first to know

Receive all the latest information on events, sales, & offers.

Terms and Conditions of Purchase

Your Use of Our Web Site

Unless specified otherwise, your use of this Web Site is governed by this Terms and Conditions of Use Agreement and the Privacy Policy, which is incorporated herein by this reference. In using this Web Site, you are prohibited from modifying, distributing, transmitting, reproducing, publishing, licensing, transferring, or selling any information, products or services obtained or viewed on this Web Site. However, you may display, download, or print hard copies of any material contained on this Web Site for your own personal, non-commercial use as long as you do not modify the content or delete any copyright, trademark, or other proprietary notice. Any other use of the information contained on this Web Site is prohibited without our express written consent.

All ACH/e-Check payments will be made payable to:

P-Sciences, Inc.

Each time I (the customer) places an ACH/e-Check order by clicking the "Place Order" button, I am authorizing to initiate a single ACH/electronic debit to my account in the amount of my order from the bank account information provided on the date of my order. I agree that ACH transactions I authorize comply with all applicable law. Payments made after 11 P.M. pacific time will be applied as of the next business day. To complete the payment process, click the “Place Order” button. Once payment is authorized, there cannot be any changes or corrections. It is recommended that you print a copy of this authorization and maintain it for your records.

Use of Information

This Web site provides information that, while useful, must not be used as a substitute for the advice of your own advisors. Information available from this Web Site is not intended to be used to diagnose any medical condition or disease. Products on this website are sold for laboratory research purposes only.

reserves the right to correct any inaccuracies or typographical errors in the information posted on this Web Site, and shall have no liability for such errors. Information may be changed or updated without notice and prices and availability of goods and services are subject to change without notice.

DISCLAIMER:

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

The products we offer are intended for IN-VITRO LABORATORY RESEARCH USE ONLY-- NOT FOR HUMAN USE.

In purchasing any of these items, the customer acknowledges that there are risks involved with consumption or distribution of these products.

These chemicals are NOT intended to use as food additives, drugs, household chemicals or other inappropriate applications.

The listing of a material on this site does not constitute a license to its use in infringement of any patent.

All of the products will be handled only by qualified and properly trained RESEARCH or LABORATORY professionals only.

Due to the nature of these products ALL SALES ARE FINAL. WE CANNOT ACCEPT RETURNS. ALL SALES ARE FINAL.

All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following:

Use of the products and more specifically In-vitro Research use of the products.

Your specific countries Government regulations regarding the use of and exposure to all products.

The health and safety hazards associated with the handling of the products they purchase.

The necessity of adequately warning of the health and safety hazards associated with any products.

reserves the right to limit and/or deny sales of products to any unqualified individuals. All customers MUST be at least 21 years of age to purchase our products. IN NO CIRCUMSTANCE SHALL BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, WHETHER PURCHASER'S CLAIM IN CONTRACT, NEGLIGENCE, STRICT LIABILITY OR OTHERWISE. IN DIRECT CONSIDERATION OF APPROVING THE SALE OF ANY PRODUCT TO THE PURCHASER, THE PURCHASER AGREES TO INDEMNIFY AND HOLD US HARMLESS FROM ALL CLAIMS, EXPENSES, LOSSES AND LIABILITY OF ANY TYPE ARISING OUT OF THE PURCHASER'S HANDLING, POSSESSION, AND/OR USE OF THE PRODUCT, WHETHER USED ALONE OR IN COMBINATION WITH ANY SUBSTANCE. ANY SALE WOULD BE DENIED OTHERWISE.

PRODUCT USE:

products are intended for laboratory IN-VITRO RESEARCH PURPOSES ONLY-- NOT FOR HUMAN USE and are not to be used for any other purposes, including but not limited to food and/or drugs, medical devices, vitro diagnostic purpose, or for commercial purposes. The purchaser agrees that the products have not been sterilized or tested by for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. The purchaser expressly represents and warrants to that the purchaser will properly test, use, manufacture and market any products purchased from and/or materials produced with products purchased from in accordance with the practices of a reliable person who is experienced in the field and in strict compliance with all applicable laws and regulations, now and hereinafter enacted. The purchaser further warrants that any material produced with any product shall not be adulterated or misbranded within the meaning of the Federal Food, Drug, and Cosmetic Act and shall not be materials which may not, under Sections 404, 505, or 512 of the Act, be introduced into interstate commerce.

The purchaser realizes that, since products are, unless otherwise stated, intended solely for in-vitro research purposes, they may not be on the Toxic Substances Control Act (TSCA) inventory listing. The purchaser assumes responsibility to assure that the products purchased from are approved for use under TSCA, if applicable.

Purchaser has the responsibility to verify the hazards and to conduct any further research necessary to learn the hazards involved in using products purchased from Purchaser agrees to comply with instructions, if any, furnished by relating to the use of the products and not misuse the products in any manner. No products purchased from shall, unless otherwise stated, be considered to be foods, drugs, or medical devices.

ALL products and services offered are for IN-VITRO RESEARCH purposes ONLY and are NOT TO BE INGESTED or CONSUMED IN ANY MANNER.

ALL PRODUCTS SOLD BY THE ARE NOT TO BE USED FOR PERSONAL USE OR FOR THE TREATMENT OF ANY MEDICAL CONDITION OR DISEASE.

Under NO circumstances shall/ should ANY of these materials be used for recreational purposes nor human consumption of any kind.

is NOT liable for ANY damages that may be caused by negligence, abuse, or ANY other unforeseen matter.

All items sold are legal for sale for IN-VITRO RESEARCH PURPOSES SPECIFICALLY within the USA.

Trade-Marks and Other Intellectual Property Rights

"" is a registered trademark of

All text, graphics, user interfaces, visual interfaces, photographs, trademarks, logos, sounds, music, artwork and computer code (collectively, "Content"), including but not limited to the design, structure, selection, coordination, expression, "look and feel" and arrangement of such Content, contained on this Web Site is owned, controlled or licensed by or to and is protected by copyright, patent and trademark laws, and various other intellectual property rights and unfair competition laws.

Except as expressly provided in this Terms and Conditions of Use Agreement, no part of this Web Site and no Content may be copied, reproduced, republished, uploaded, posted, publicly displayed, encoded, translated, transmitted or distributed in any way (including "mirroring") to any other computer, server, web site or other medium for publication or distribution or for any commercial enterprise, without express prior written consent.

Indemnity

You hereby agree to indemnify and hold and our subsidiaries, affiliates, officers, directors, agents, co-branders, partners, and employees harmless from any claim or demand, including reasonable attorney's fees, made by any third party due to or arising out of your use of the content on this Web Site, or any content you submit, post, or transmit through this Web Site, your use of this Web Site, your connection to this Web site, your violation of this Terms and Conditions of Use Agreement, or your violation of any rights of another.

Links/Software

Links from or to websites outside this Web Site are meant for convenience only. does not review, endorse, approve or control, and is not responsible for any sites linked from or to this Web Site, the content of those sites, the third parties named therein, or their products or services. Linking to any other site is at your sole risk and will not be responsible or liable for any damages in connection with linking. disclaims all warranties, express and implied as to the accuracy, validity and legality of any materials or information found on those sites. Links to downloadable software sites are for convenience only and is not responsible or liable for any difficulties or consequences associated with downloading the software. Use of any downloaded software is governed by the terms of the license agreement, if any, which accompanies or is provided with the software.

Availability of Our Web Site

This Web Site is generally available to users Twenty-four (24) hours per day, Seven (7) days per week, Three Hundred Sixty-five (365) days per year. However, retains the right to make our Web Site unavailable at any time, for any reason, and for any length of time. By using this Web Site you agree that will not be liable for any damage arising out of or related to any such interruption, suspension, or termination of this Web Site and/or the services or products contained therein. Upon acceptance of these terms and conditions of use authorizes you to view the Content on the Web Site solely for your personal use. The material on the Web Site is intended solely for individuals enquiring about products or services. If you are not accessing the Web Site for such purposes, you may not use the Web Site. For certainty, use by non-individuals or the agents, attorneys or representatives of non-individuals is prohibited.

**Information You Provide

Our collection and/or use of any information you provide while using or visiting this Web Site is governed by the Privacy Policy and this Terms and Conditions of Use Agreement. By using this Web Site you grant us the rights contained therein. In using this Web Site you may not upload, distribute, or otherwise publish on this Web Site any information which may be viewed as obscene, defamatory, libelous, threatening, abusive, illegal, an invasion of privacy rights, or otherwise objectionable, or may constitute or encourage a violation of any law.

Except for that individually-identifiable information collected from you in accordance with our Privacy Policy, all comments, remarks, suggestions, ideas or other information communicated will become the exclusive property of and you grant to a royalty-free, perpetual, irrevocable, world-wide, non-exclusive license to use or reproduce the same. is free to copy, disclose, distribute or analyze any such information for any and all purposes and are in no way obligated to compensate you for any such information.

Disclaimer of Warranties

PROVIDES CONTENT ON THIS WEB SITE AS A SERVICE TO YOU, OUR CUSTOMER. THIS WEB SITE CANNOT AND DOES NOT, CONTAIN INFORMATION ABOUT ALL APPLICATIONS FOR PRODUCTS SOLD. IT MAY NOT CONTAIN ALL INFORMATION THAT IS APPLICABLE TO YOUR PERSONAL CIRCUMSTANCES OR YOUR USE OF PRODUCTS SOLD. THE CONTENT OF THIS WEB SITE, THE WEB SITE SERVER THAT MAKES IT AVAILABLE, AND THE SERVICES AND PRODUCTS PROVIDES ON THIS WEB SITE, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTY OF ANY KIND, WHETHER EXPRESS, IMPLIED OR STATUTORY. EXPRESSLY DISCLAIMS LIABILITY FOR TECHNICAL FAILURES (INCLUDING HARDWARE OR SOFTWARE FAILURES), INCOMPLETE, SCRAMBLED OR DELAYED COMPUTER TRANSMISSIONS, AND/OR TECHNICAL INACCURACIES, AS WELL AS UNAUTHORIZED ACCESS OF USER TRANSMISSIONS BY THIRD PARTIES. FURTHER, DOES NOT REPRESENT OR WARRANT THAT NO VIRUSES OR OTHER CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE TRANSMITTED, OR THAT NO DAMAGE WILL OCCUR TO YOUR COMPUTER SYSTEM. YOU HAVE SOLE RESPONSIBILITY FOR ADEQUATE PROTECTION AND BACKUP OF DATA AND/OR EQUIPMENT AND TO TAKE ALL PRECAUTIONS TO SCAN FOR COMPUTER VIRUSES OR OTHER DESTRUCTIVE PROPERTIES. BY YOUR USE OF THIS WEB SITE, YOU ACKNOWLEDGE THAT SUCH USE IS AT YOUR SOLE RISK, INCLUDING RESPONSIBILITY FOR ALL COSTS ASSOCIATED WITH ALL NECESSARY SERVICING OR REPAIRS OF ANY EQUIPMENT YOU USE IN CONNECTION WITH THIS WEB SITE.

TO THE FULL EXTENT NOT PRECLUDED BY APPLICABLE LAW THEIR MEDICAL ADVISORS, SUPPLIERS, CONSULTANTS, DIRECTORS AND EMPLOYEES DISCLAIM AND EXCLUDE ALL WARRANTIES WITH RESPECT TO ALL CONTENT, EXPRESS, IMPLIED OR STATUTORY. THIS DISCLAIMER INCLUDES, BUT IS NOT LIMITED TO, ANY AND ALL WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. DOES NOT WARRANT THE CONTENT TO BE ACCURATE, COMPLETE OR CURRENT. DOES NOT WARRANT THAT THIS WEB SITE WILL OPERATE WITHOUT ERROR, THAT DEFECTS WILL BE CORRECTED OR THAT THIS WEB SITE OR THE WEB SITE SERVER MAKING IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. PRICE AND AVAILABILITY CONTENT, AS WELL AS OTHER CONTENT CONTAINED IN THIS WEB SITE OR ACCESSIBLE THEREFROM, IS SUBJECT TO CHANGE WITHOUT NOTICE.

YOU ACKNOWLEDGE AND AGREE THAT DOES NOT ENDORSE THE CONTENT OF ANY SITE ACCESSED VIA LINKS OR OTHER MEANS FROM THIS WEB SITE AND IT IS NOT RESPONSIBLE OR LIABLE FOR SUCH CONTENT EVEN THOUGH IT MAY BE UNLAWFUL, HARASSING, LIBELOUS, PRIVACY INVADING, ABUSIVE, THREATENING, HARMFUL, OBSCENE, OR OTHERWISE OBJECTIONABLE, OR THAT IT INFRINGES OR MAY INFRINGE THE INTELLECTUAL PROPERTY OR OTHER RIGHTS OF ANOTHER PERSON.

THIS WEB SITE INCLUDES CONTENT PROVIDED BY THIRD PARTIES AND YOU, OUR CUSTOMER. IS A DISTRIBUTOR OF SUCH CONTENT AND NOT ITS PUBLISHER. EDITORIAL CONTROL OF SUCH CONTENT IS THE SAME AS THAT OF A PUBLIC LIBRARY OR NEWSSTAND. THIRD PARTY SUPPLIERS MAY EXPRESS CERTAIN OPINIONS OR PROVIDE CERTAIN INFORMATION AND OFFERS. MAKES NO WARRANTIES AS TO THE COMPLETENESS, ACCURACY, TIMELINESS, OR RELIABILITY OF INFORMATION OR OFFERS SUPPLIED BY THIRD PARTIES. DOES NOT GUARANTEE OR WARRANT THE PERFORMANCE OF ANY THIRD PARTY, INCLUDING ANY SUCH THIRD PARTY’S CONFORMANCE TO ANY LAW, RULE, REGULATION OR POLICY.

DOES NOT WARRANT THAT INFORMATION, SERVICES, AND PRODUCTS CONTAINED IN THIS WEB SITE WILL SATISFY YOUR REQUIREMENTS OR THAT THEY ARE ERROR OR DEFECT-FREE. BEFORE USING ANY PRODUCT YOU SHOULD CONFIRM ANY INFORMATION OF IMPORTANCE TO YOU ON THE PRODUCT PACKAGING. YOU ASSUME RESPONSIBILITY FOR THE ACCURACY, APPROPRIATENESS AND LEGALITY OF ANY INFORMATION YOU SUPPLY

AS PARTIAL CONSIDERATION FOR YOUR ACCESS TO THIS WEB SITE AND USE OF ITS CONTENT, YOU AGREE THAT IS NOT LIABLE TO YOU IN ANY MANNER WHATSOEVER FOR DECISIONS YOU MAY MAKE OR YOUR ACTIONS OR NON-ACTIONS IN RELIANCE UPON THE CONTENT. YOU ALSO AGREE THAT THE AGGREGATE LIABILITY OF ARISING FROM OR RELATED TO YOUR USE AND ACCESS REGARDLESS OF THE FORM OF ACTION OR CLAIM (FOR EXAMPLE, CONTRACT, WARRANTY, TORT, NEGLIGENCE, STRICT LIABILITY, PROFESSIONAL MALPRACTICE, FRAUD, OR OTHER BASES FOR CLAIMS), IS LIMITED TO THE PURCHASE PRICE OF ANY ITEMS YOU PURCHASED FROM IN THE APPLICABLE TRANSACTION. SHALL NOT IN ANY CASE BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES EVEN IF HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS IS A COMPREHENSIVE LIMITATION OF LIABILITY THAT APPLIES TO ALL LOSES AND DAMAGES OF ANY KIND. IF YOU ARE DISSATISFIED WITH THIS WEB SITE OR ITS CONTENT (INCLUDING TERMS OF USE), YOUR SOLE EXCLUSIVE REMEDY IS TO DISCONTINUE USING THIS WEB SITE. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, SUCH LIMITATION MAY NOT BE APPLICABLE TO YOU.

Your Agreement to Abide by All Applicable Laws

By using this Web Site you agree to comply with any and all local, state, or federal laws, statutes, and regulations that relate in any manner to the use of this Web Site and the associated services or products contained thereon.

Relationship between and Users.

and users of our Site are independent contractors, and no agency, partnership, employment or other relationship is created or is intended to be created by the use of our Web Site.

Governing Law and Jurisdiction

This Web Site (excluding linked sites, if any) is administered and controlled by and its affiliates, subsidiaries, officers, directors, employees or agents from its offices in the accordance with the laws of Nevis. You agree that this Terms and Conditions of Use Agreement and this Web Site will be governed by and construed in accordance Nevis law without giving effect to any principles of conflicts of laws. You access this Web Site and/or associated services of at your own risk, and remain responsible for complying with the laws of the jurisdiction within which you are located.

Prices; Payment Terms; Interest

The prices for the products and services on this Web Site are quoted, for convenience, in United States dollars and shall be as set forth in this Web Site as at the time of acceptance of an order by Prices for Products shall be subject to change without any further notice. Credit terms are within sole discretion, and unless otherwise specified in invoice, payment must be received by prior to acceptance of an order.

Consequences

reserves the right to suspend or terminate your account if you violate the Terms of Use Agreement. If your violation causes harm to others, you agree to indemnify and hold harmless from and against any and all loss, damage, or expense. If any dispute arises between us regarding this Agreement or your use of this Web Site, it shall be resolved through good faith negotiations between the parties.

Entire Agreement

These Terms and Conditions and any terms incorporated or referred to herein constitute the entire agreement between and you relating to your use of this Web Site and the subject matter hereof, and supersede any prior understandings or agreements (whether electronic, oral or written) regarding the subject matter, and may not be amended or modified except in writing, or by making such amendments or modifications in accordance with this Terms and Conditions of Use Agreement.

Severability

If any part of this Terms and Conditions of Use Agreement is deemed or determined to be unenforceable, then such part shall be eliminated or limited to the minimum extent necessary. The remainder of this Terms and Conditions of Use Agreement, including any revised portion, shall remain and be in full force and effect. This Terms and Conditions of Use Agreement are the entire agreement between us governing your use of this Web Site.

Headings

The headings contained in this Terms and Conditions of Use Agreement and the Privacy Policy are for reference only.

Force Majeure

shall not be liable for any delay or failure in performance caused by circumstances beyond its reasonable control, including, without limitation, delays due to backorders of requested products, mail delays, customs delays or lost shipments. shall not be responsible to notify the Customer in the event of such delays. The Customer shall be solely responsible to make other arrangements to purchase alternative products and any costs incurred in connection with such purchases.

Thank you again for visiting the Web Site.

Complete Agreement

Except as expressly provided in a particular "legal notice" on this Site, these Terms and Conditions constitute the entire agreement between you and this Site with respect to the use of this Site, and Content. By clicking “I agree” when placing your order, you agree with ALL OF OUR TERMS and CONDITIONS as stated above as well as our Shipping and refunds Policy.

Thank you for your cooperation.

Terms and Conditions of Purchase

Your Use of Our Web Site

Use of Information

DISCLAIMER:

Shipping address will be selected within Apple Pay. Any address entered in checkout will not be used.